查看購物車
  • Simplified Chinese
  • English
  • Japanese
非洲抗癌藥物市場規模及預測（2021 - 2031 年）、區域佔有率、趨勢及成長機會分析報告，涵蓋：依藥物類別、適應症、劑型、療法、產業及國家/地區
市場調查報告書
商品編碼
1761149

非洲抗癌藥物市場規模及預測（2021 - 2031 年）、區域佔有率、趨勢及成長機會分析報告，涵蓋：依藥物類別、適應症、劑型、療法、產業及國家/地區

Africa Anticancer Drugs Market Size and Forecast 2021 - 2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Dosage Form, Therapy, Sector, and Country
出版日期: | 出版商: The Insight Partners | 英文 315 Pages | 訂單完成後即時交付

價格

預計非洲抗癌藥物市場規模將從 2024 年的 18.1 億美元增至 2031 年的 32.3 億美元。預計 2025 年至 2031 年期間該市場的複合年成長率為 8.8%。

本報告提供的非洲抗癌藥物市場預測可以幫助該市場的利害關係人規劃其成長策略。癌症發生率的上升以及提高癌症意識的舉措的不斷湧現是推動非洲抗癌藥物市場成長的關鍵因素。

人工智慧加速癌症治療

人工智慧 (AI) 正在成為抗癌藥物市場的一股變革力量，應對與基因多樣性、臨床資料匱乏以及個人化治療途徑有限相關的關鍵挑戰。隨著非洲大陸癌症病例的大幅增加，人工智慧正在加速藥物研發、最佳化治療方案並促進本土創新。人工智慧在癌症篩檢、診斷和護理領域的實際應用，為早期癌症識別打開了大門，並加速了針對每位患者制定全新治療方案的發展。

開普敦大學、葛蘭素史克、諾華和南非醫學研究委員會合作的「非洲梯度計畫」（Project Africa GRADIENT）體現了人工智慧在根據非洲基因譜定製藥物方面的作用。該計劃旨在透過考慮影響藥物反應的基因變異，提高針對非洲人群的治療方案的療效。這種方法確保療法更有效、副作用更少，從而顯著改善患者的治療效果。此外，人工智慧透過分析大量生物資料來識別潛在的候選藥物，從而加速藥物研發過程。 Insilico Medicine 等公司利用人工智慧驅動的平台設計小分子療法並發現藥物靶點，將藥物研發時間從數年縮短至數月。這種快速發展對於應對非洲日益加重的癌症負擔至關重要，因為非洲的早期檢測和治療方案通常有限。 2023 年 4 月，全球製藥公司阿斯特捷利康與南非健康科技公司 MedSol AI Solutions 合作，推動人工智慧在乳癌檢測的應用。雙方合作的核心是開發一種先進的 Wi-Fi 超音波探頭，該探頭能夠在幾秒鐘內識別出乳癌。他們的 Melusi 乳房 AI 快速檢測應用程式將部署在鄉村診所，以支援早期診斷，尤其是在醫療資源匱乏的地區。該計劃將配備專門的轉診系統，確保檢測結果呈陽性的女性能夠及時獲得治療介入。因此，將 AI 融入非洲的癌症治療領域將提升治療效果，並促進醫學研發的自主發展。透過利用 AI，非洲國家可以應對遺傳多樣性和個人化醫療資源有限帶來的獨特挑戰，為更公平的醫療保健解決方案鋪平道路。因此，透過實現個人化治療、加速藥物開發和促進包容性研究，AI 正在引領非洲抗癌藥物市場的新趨勢。

根據藥物類別，非洲抗癌藥物市場細分為細胞毒性藥物、標靶藥物、荷爾蒙藥物、免疫治療藥物、基因治療藥物、放射性藥物及其他。細胞毒性藥物在2024年佔據最大佔有率。標靶藥物預計在2025-2031年期間將達到最高複合年成長率。

根據適應症，非洲抗癌藥物市場細分為肺癌、胃癌、大腸癌、乳癌、攝護腺癌等。肺癌領域在2024年佔據了最大的市場佔有率，而乳癌領域預計在2025-2031年期間將實現最高的複合年成長率。

就治療類型而言，非洲抗癌藥物市場分為化療、標靶治療、免疫治療、基因治療、放射性藥物治療及其他。化療領域在2024年佔據最大市場佔有率，預計在2025年至2031年期間將實現最高的複合年成長率。

根據劑型，非洲抗癌藥物市場分為片劑和膠囊劑、注射劑和液體劑。片劑和膠囊劑在2024年佔據了最大的市場佔有率，預計在2025年至2031年期間，該細分市場將實現最高的複合年成長率。

按行業分類，市場分為公共部門和私營部門。 2024年，公共部門佔據了更大的市場。預計私營部門在2025年至2031年期間的複合年成長率將更高。

在撰寫非洲抗癌藥物市場報告時參考的一些主要一手和二手資料來源包括 GLOBOCAN - IARC、WHO 癌症國家概況、WHO 全球衛生觀察站、聯合國商品貿易統計資料庫、IAEA DIRAC、世界銀行、WHO 全球衛生支出資料庫、各國衛生部（例如埃及 CAPA、奈及利亞 NHIS）、非洲藥品管理局 (AMA)、BMI Fitch）。

目錄

第1章：簡介

第2章：執行摘要

  • 分析師市場展望

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：非洲抗癌藥物市場格局

  • 概述
  • PEST分析
  • 各國癌症盛行率
  • 癌症治療：2024 年定價分析
  • 非洲進出口狀況
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：非洲抗癌藥物市場-關鍵市場動態

  • 非洲抗癌藥物市場－關鍵市場動態
  • 市場促進因素
    • 癌症發生率上升
    • 加強提高癌症認知的舉措
  • 市場限制
    • 抗癌藥物價格昂貴且供應有限
  • 市場機會
    • 臨床試驗數量激增
  • 未來趨勢
    • 人工智慧加速癌症治療
  • 促進因素和限制因素的影響：

第6章：非洲抗癌藥物市場-全球市場分析

  • 2021-2031年非洲抗癌藥物市場收入
  • 非洲抗癌藥物市場預測分析

第7章：非洲抗癌藥物市場分析－依藥物類別

  • 細胞毒性藥物
  • 標靶藥物
  • 荷爾蒙藥物
  • 免疫治療藥物
  • 基因治療藥物
  • 放射性藥物
  • 其他

第8章：非洲抗癌藥物市場分析-按適應症

  • 肺癌
  • 胃癌
  • 大腸直腸癌
  • 乳癌
  • 攝護腺癌
  • 其他

第9章：非洲抗癌藥物市場分析－按劑型

  • 片劑和膠囊
  • 注射劑
  • 液體

第10章：非洲抗癌藥物市場分析-按療法

  • 化療
  • 標靶治療
  • 免疫療法
  • 基因治療
  • 放射性藥物治療
  • 其他

第 11 章：非洲抗癌藥物市場分析 - 按行業

  • 私人的
  • 民眾

第12章：非洲抗癌藥物市場-地理分析

  • 非洲
    • 南非
    • 埃及
    • 阿爾及利亞
    • 摩洛哥
    • 突尼西亞
    • 奈及利亞
    • 肯亞
    • 衣索比亞
    • 迦納
    • 科特迪瓦（象牙海岸）
    • 塞內加爾
    • 利比亞
    • 非洲其他地區

第 13 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 14 章：產業格局

  • 概述
  • 市場計劃
  • 夥伴關係與合作
  • 其他發展

第15章：公司簡介

  • Amgen Inc
  • Gilead Sciences Inc
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • BeiGene Ltd
  • Takeda Pharmaceutical Co Ltd
  • GSK Plc
  • Sanofi SA
  • Cipla Ltd
  • Johnson & Johnson
  • Aspen Holdings
  • Pfizer Inc
  • AstraZeneca Plc
  • Merck & Co Inc
  • Daiichi Sankyo Co Ltd

第 16 章：附錄

Product Code: TIPRE00040929

The Africa anticancer drugs market is expected to reach US$ 3.23 billion by 2031 from US$ 1.81 billion in 2024. The market is estimated to grow with a CAGR of 8.8% from 2025 to 2031.

The Africa anticancer drugs market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. The increasing incidence of cancer and surging initiatives to improve cancer awareness are the key factors propelling the Africa anticancer drugs market growth.

Artificial Intelligence Accelerating Cancer Care

Artificial Intelligence (AI) is emerging as a transformative force in the anticancer drugs market, addressing critical challenges associated with genetic diversity, scarce clinical data, and limited access to personalized treatments. Amid the vast increase in cancer cases across the continent, AI is accelerating drug discovery, optimizing treatments, and fostering local innovation. The practical application of AI in cancer screening, diagnosis, and care opens the door for early cancer identification and accelerates the development of new treatment plans tailored to each patient.

Project Africa GRADIENT, a collaboration between the University of Cape Town, GlaxoSmithKline, Novartis, and the South African Medical Research Council, exemplifies AI's role in tailoring drugs to African genetic profiles. This initiative aims to enhance the efficacy of treatments designed for African populations by considering genetic variations that influence drug responses. This approach ensures that therapies are more effective and have fewer side effects, significantly improving patient outcomes. Additionally, AI accelerates the drug discovery process by analyzing vast amounts of biological data to identify potential drug candidates. Companies such as Insilico Medicine employ AI-driven platforms to design small-molecule treatments and discover drug targets, reducing drug development timelines from years to months. This rapid development is crucial for addressing the increasing cancer burden in Africa, where early detection and treatment options are often limited. In April 2023, AstraZeneca (a global pharmaceutical company) joined forces with South African health-tech firm MedSol AI Solutions to advance the use of AI in breast cancer detection. Their collaboration centers around a cutting-edge Wi-Fi-enabled ultrasound probe capable of identifying breast cancer within seconds. Their Melusi Breast AI rapid detection app will be deployed in rural clinics to support early diagnosis, particularly in underserved areas. A dedicated referral system backs the initiative to ensure that women with positive results can access timely therapeutic interventions. Thus, AI integration into the cancer care landscape in Africa would enhance treatment outcomes and promote self-reliance in medical research and development. By harnessing AI, African nations can address the unique challenges posed by genetic diversity and limited access to personalized care, paving the way for more equitable healthcare solutions. Hence, by enabling personalized treatments, accelerating drug development, and fostering inclusive research, AI is setting new trends in the Africa anticancer drugs market.

Based on drug class, the Africa anticancer drugs market is segmented into cytotoxic drugs, targeted drugs, hormonal drugs, immunotherapy drugs, gene therapy drugs, radiopharmaceuticals, and others. The cytotoxic drugs segment held the largest share in 2024. The targeted drugs segment is expected to register the highest CAGR during 2025-2031.

Based on indication, the Africa anticancer drugs market is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, and others. The lung cancer segment held the largest market share in 2024, and the breast cancer segment is estimated to register the highest CAGR in the market during 2025-2031.

In terms of therapy type, the Africa anticancer drugs market is categorized into chemotherapy, targeted therapy, immunotherapy, gene therapy, radiopharmaceutical therapy, and others. The chemotherapy segment held the largest market share in 2024, and the same segment is estimated to register the highest CAGR in the market during 2025-2031.

Based on dosage form, the Africa anticancer drugs market is categorized into tablet and capsule, injectable, and liquid. The tablet and capsule segment held the largest market share in 2024, and the same segment is estimated to register the highest CAGR in the market during 2025-2031.

By sector, the market is bifurcated into public and private. The public segment held a larger share of the market in 2024. The private segment is estimated to register a higher CAGR during 2025-2031.

A few of the major primary and secondary sources referred to while preparing the report on the Africa anticancer drugs market are the GLOBOCAN - IARC, WHO Cancer Country Profiles, WHO Global Health Observatory, UN Comtrade Database, IAEA DIRAC, World Bank, WHO Global Health Expenditure Database, Ministries of Health (e.g., Egypt CAPA, Nigeria NHIS), African Medicines Agency (AMA), BMI Fitch).

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. African Anticancer Drugs Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Cancer Prevalence, By Country
  • 4.4 Cancer Therapeutics: Pricing Analysis, 2024
  • 4.5 Import-export Scenario in Africa
  • 4.6 Ecosystem Analysis
    • 4.6.1 List of Vendors in the Value Chain

5. African Anticancer Drugs Market - Key Market Dynamics

  • 5.1 African Anticancer Drugs Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Cancer Incidence
    • 5.2.2 Increasing Initiatives to Improve Cancer Awareness
  • 5.3 Market Restraints
    • 5.3.1 Unaffordability and Limited Availability of Cancer Drugs
  • 5.4 Market Opportunities
    • 5.4.1 Surging Number of Clinical Trials
  • 5.5 Future Trends
    • 5.5.1 Artificial Intelligence Accelerating Cancer Care
  • 5.6 Impact of Drivers and Restraints:

6. African Anticancer Drugs Market - Global Market Analysis

  • 6.1 African Anticancer Drugs Market Revenue (US$ Million), 2021-2031
  • 6.2 African Anticancer Drugs Market Forecast Analysis

7. African Anticancer Drugs Market Analysis - by Drug Class Type

  • 7.1 Cytotoxic Drugs
    • 7.1.1 Overview
    • 7.1.2 Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Targeted Drugs
    • 7.2.1 Overview
    • 7.2.2 Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Hormonal Drugs
    • 7.3.1 Overview
    • 7.3.2 Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Immunotherapy Drugs
    • 7.4.1 Overview
    • 7.4.2 Immunotherapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Gene Therapy Drugs
    • 7.5.1 Overview
    • 7.5.2 Gene Therapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Radiopharmaceuticals
    • 7.6.1 Overview
    • 7.6.2 Radiopharmaceuticals: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

8. African Anticancer Drugs Market Analysis - by Indication

  • 8.1 Lung Cancer
    • 8.1.1 Overview
    • 8.1.2 Lung Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Stomach Cancer
    • 8.2.1 Overview
    • 8.2.2 Stomach Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Colorectal Cancer
    • 8.3.1 Overview
    • 8.3.2 Colorectal Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Breast Cancer
    • 8.4.1 Overview
    • 8.4.2 Breast Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Prostrate Cancer
    • 8.5.1 Overview
    • 8.5.2 Prostrate Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

9. African Anticancer Drugs Market Analysis - by Dosage Form

  • 9.1 Tablet and Capsule
    • 9.1.1 Overview
    • 9.1.2 Tablet and Capsule: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Injectable
    • 9.2.1 Overview
    • 9.2.2 Injectable: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Liquid
    • 9.3.1 Overview
    • 9.3.2 Liquid: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

10. African Anticancer Drugs Market Analysis - by Therapy

  • 10.1 Chemotherapy
    • 10.1.1 Overview
    • 10.1.2 Chemotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Targeted Therapy
    • 10.2.1 Overview
    • 10.2.2 Targeted Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Immunotherapy
    • 10.3.1 Overview
    • 10.3.2 Immunotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Gene Therapy
    • 10.4.1 Overview
    • 10.4.2 Gene Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Radiopharmaceutical Therapy
    • 10.5.1 Overview
    • 10.5.2 Radiopharmaceutical Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

11. African Anticancer Drugs Market Analysis - by Sector

  • 11.1 Private
    • 11.1.1 Overview
    • 11.1.2 Private: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Public
    • 11.2.1 Overview
    • 11.2.2 Public: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

12. African Anticancer Drugs Market - Geographical Analysis

  • 12.1 Africa
    • 12.1.1 African Anticancer Drugs Market Overview
    • 12.1.2 African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
      • 12.1.2.1 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Drug Class Type
      • 12.1.2.2 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Cytotoxic Drugs
      • 12.1.2.3 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Targeted Drugs
      • 12.1.2.4 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Hormonal Drugs
      • 12.1.2.5 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Indication
      • 12.1.2.6 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Dosage Form
      • 12.1.2.7 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Therapy
      • 12.1.2.8 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Sector
    • 12.1.3 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.1.1 South Africa: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.1.2 South Africa: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.1.3 South Africa: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.1.4 South Africa: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.1.5 South Africa: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.1.6 South Africa: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.1.7 South Africa: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.1.8 South Africa: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.2 Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.2.1 Egypt: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.2.2 Egypt: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.2.3 Egypt: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.2.4 Egypt: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.2.5 Egypt: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.2.6 Egypt: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.2.7 Egypt: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.2.8 Egypt: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.3 Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.3.1 Algeria: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.3.2 Algeria: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.3.3 Algeria: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.3.4 Algeria: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.3.5 Algeria: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.3.6 Algeria: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.3.7 Algeria: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.3.8 Algeria: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.4 Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.4.1 Morocco: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.4.2 Morocco: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.4.3 Morocco: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.4.4 Morocco: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.4.5 Morocco: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.4.6 Morocco: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.4.7 Morocco: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.4.8 Morocco: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.5 Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.5.1 Tunisia: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.5.2 Tunisia: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.5.3 Tunisia: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.5.4 Tunisia: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.5.5 Tunisia: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.5.6 Tunisia: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.5.7 Tunisia: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.5.8 Tunisia: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.6 Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.6.1 Nigeria: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.6.2 Nigeria: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.6.3 Nigeria: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.6.4 Nigeria: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.6.5 Nigeria: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.6.6 Nigeria: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.6.7 Nigeria: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.6.8 Nigeria: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.7 Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.7.1 Kenya: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.7.2 Kenya: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.7.3 Kenya: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.7.4 Kenya: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.7.5 Kenya: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.7.6 Kenya: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.7.7 Kenya: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.7.8 Kenya: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.8 Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.8.1 Ethiopia: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.8.2 Ethiopia: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.8.3 Ethiopia: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.8.4 Ethiopia: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.8.5 Ethiopia: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.8.6 Ethiopia: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.8.7 Ethiopia: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.8.8 Ethiopia: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.9 Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.9.1 Ghana: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.9.2 Ghana: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.9.3 Ghana: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.9.4 Ghana: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.9.5 Ghana: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.9.6 Ghana: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.9.7 Ghana: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.9.8 Ghana: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.10 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.10.1 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.10.2 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.10.3 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.10.4 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.10.5 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.10.6 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.10.7 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.10.8 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.11 Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.11.1 Senegal: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.11.2 Senegal: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.11.3 Senegal: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.11.4 Senegal: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.11.5 Senegal: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.11.6 Senegal: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.11.7 Senegal: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.11.8 Senegal: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.12 Libya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.12.1 Libya: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.12.2 Libya: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.12.3 Libya: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.12.4 Libya: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.12.5 Libya: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.12.6 Libya: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.12.7 Libya: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.12.8 Libya: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.13 Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.13.1 Rest of Africa: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.13.2 Rest of Africa: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.13.3 Rest of Africa: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.13.4 Rest of Africa: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.13.5 Rest of Africa: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.13.6 Rest of Africa: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.13.7 Rest of Africa: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.13.8 Rest of Africa: African Anticancer Drugs Market Breakdown, by Sector

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Industry Landscape

  • 14.1 Overview
  • 14.2 Market Initiative
  • 14.3 Partnerships and Collaborations
  • 14.4 Other Developments

15. Company Profiles

  • 15.1 Amgen Inc
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Gilead Sciences Inc
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Novartis AG
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 F. Hoffmann-La Roche Ltd
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 BeiGene Ltd
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Takeda Pharmaceutical Co Ltd
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 GSK Plc
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Sanofi SA
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Cipla Ltd
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Johnson & Johnson
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 Aspen Holdings
    • 15.11.1 Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 Pfizer Inc
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments
  • 15.13 AstraZeneca Plc
    • 15.13.1 Key Facts
    • 15.13.2 Business Description
    • 15.13.3 Products and Services
    • 15.13.4 Financial Overview
    • 15.13.5 SWOT Analysis
    • 15.13.6 Key Developments
  • 15.14 Merck & Co Inc
    • 15.14.1 Key Facts
    • 15.14.2 Business Description
    • 15.14.3 Products and Services
    • 15.14.4 Financial Overview
    • 15.14.5 SWOT Analysis
    • 15.14.6 Key Developments
  • 15.15 Daiichi Sankyo Co Ltd
    • 15.15.1 Key Facts
    • 15.15.2 Business Description
    • 15.15.3 Products and Services
    • 15.15.4 Financial Overview
    • 15.15.5 SWOT Analysis

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms

List Of Tables

  • Table 1. African Anticancer Drugs Market Segmentation
  • Table 2. Methodology 1 - Africa Market
  • Table 3. Methodology 2 - Africa Market
  • Table 4. Each country's market share is determined using five weighted parameters:
  • Table 5. Market Issues in African Anti-Cancer Drugs Market
  • Table 6. Cancer Prevalence, By Country- 2023
  • Table 7. Cancer Therapeutics, Pricing Analysis (Price (US$/Unit)- 2023
  • Table 8. Import Value and Quantity of Medicinal Products by Key African Countries (2024)
  • Table 9. Export Value and Quantity of Medicinal Products by Key African Countries (2024)
  • Table 10. List of Vendors
  • Table 11. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million)
  • Table 12. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million)
  • Table 13. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 14. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 15. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 16. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 17. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 18. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 19. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Drug Class Type
  • Table 20. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 21. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Cytotoxic Drugs
  • Table 22. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 23. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Targeted Drugs
  • Table 24. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 25. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Hormonal Drugs
  • Table 26. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 27. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Indication
  • Table 28. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 29. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Dosage Form
  • Table 30. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 31. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Therapy
  • Table 32. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 33. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Sector
  • Table 34. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 35. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 36. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 37. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 38. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 39. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 40. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 41. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 42. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 43. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 44. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 45. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 46. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 47. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 48. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 49. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 50. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 51. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 52. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 53. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 54. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 55. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 56. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 57. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 58. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 59. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 60. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 61. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 62. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 63. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 64. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 65. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 66. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 67. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 68. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 69. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 70. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 71. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 72. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 73. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 74. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 75. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 76. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 77. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 78. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 79. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 80. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 81. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 82. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 83. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 84. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 85. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 86. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 87. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 88. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 89. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 90. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 91. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 92. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 93. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 94. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 95. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 96. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 97. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 98. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 99. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 100. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 101. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 102. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 103. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 104. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 105. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 106. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 107. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 108. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 109. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 110. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 111. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 112. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 113. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 114. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 115. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 116. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 117. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 118. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 119. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 120. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 121. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 122. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 123. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 124. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 125. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 126. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 127. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 128. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 129. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 130. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 131. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 132. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 133. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 134. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 135. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 136. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 137. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 138. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 139. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 140. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 141. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 142. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 143. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 144. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 145. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 146. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 147. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 148. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 149. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 150. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 151. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 152. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 153. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 154. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 155. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 156. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 157. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 158. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 159. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 160. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 161. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 162. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 163. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 164. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 165. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 166. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 167. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 168. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 169. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 170. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 171. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 172. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 173. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 174. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 175. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 176. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 177. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 178. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 179. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 180. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 181. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 182. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 183. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 184. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 185. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 186. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 187. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 188. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 189. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 190. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 191. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 192. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 193. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 194. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 195. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 196. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 197. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 198. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 199. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 200. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 201. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 202. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 203. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 204. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 205. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 206. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 207. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 208. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 209. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 210. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 211. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 212. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 213. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 214. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 215. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 216. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 217. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 218. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 219. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 220. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 221. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 222. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 223. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 224. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 225. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 226. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 227. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 228. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 229. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 230. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 231. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 232. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 233. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 234. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 235. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 236. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 237. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 238. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 239. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 240. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 241. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 242. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 243. Glossary of Terms, African Anticancer Drugs Market

List Of Figures

  • Figure 1. African Anticancer Drugs Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Ecosystem Analysis
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. African Anticancer Drugs Market Revenue (US$ Million), 2021-2031
  • Figure 6. African Anticancer Drugs Market Share (%) - by Drug Class Type (2024 and 2031)
  • Figure 7. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Immunotherapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Gene Therapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Radiopharmaceuticals: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. African Anticancer Drugs Market Share (%) - by Indication (2024 and 2031)
  • Figure 15. Lung Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Stomach Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Colorectal Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Breast Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Prostrate Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. African Anticancer Drugs Market Share (%) - by Dosage Form (2024 and 2031)
  • Figure 22. Tablet and Capsule: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Injectable: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Liquid: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. African Anticancer Drugs Market Share (%) - by Therapy (2024 and 2031)
  • Figure 26. Chemotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Targeted Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Immunotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Gene Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Radiopharmaceutical Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. African Anticancer Drugs Market Share (%) - by Sector (2024 and 2031)
  • Figure 33. Private: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. Public: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 35. African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 36. African Anticancer Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 37. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 38. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 39. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 40. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 41. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 42. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 43. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 44. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 45. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 46. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 47. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 48. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 49. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 50. Heat Map Analysis by Key Players
  • Figure 51. Company Positioning and Concentration